- Home
- PDM vs PAHC Comparison
PDM vs PAHC Comparison
Compare PDM & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDM
- PAHC
- Stock Information
- Founded
- PDM 1997
- PAHC 1946
- Country
- PDM United States
- PAHC United States
- Employees
- PDM N/A
- PAHC N/A
- Industry
- PDM Building operators
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- PDM Real Estate
- PAHC Health Care
- Exchange
- PDM Nasdaq
- PAHC Nasdaq
- Market Cap
- PDM 921.9M
- PAHC 968.3M
- IPO Year
- PDM N/A
- PAHC 2014
- Fundamental
- Price
- PDM $7.61
- PAHC $30.80
- Analyst Decision
- PDM Buy
- PAHC Hold
- Analyst Count
- PDM 5
- PAHC 4
- Target Price
- PDM $9.40
- PAHC $24.50
- AVG Volume (30 Days)
- PDM 972.7K
- PAHC 323.3K
- Earning Date
- PDM 07-28-2025
- PAHC 08-27-2025
- Dividend Yield
- PDM 6.57%
- PAHC 1.58%
- EPS Growth
- PDM N/A
- PAHC 140.17
- EPS
- PDM N/A
- PAHC 0.78
- Revenue
- PDM $568,472,000.00
- PAHC $1,190,682,000.00
- Revenue This Year
- PDM $0.50
- PAHC $28.33
- Revenue Next Year
- PDM N/A
- PAHC $13.78
- P/E Ratio
- PDM N/A
- PAHC $38.80
- Revenue Growth
- PDM N/A
- PAHC 19.12
- 52 Week Low
- PDM $5.46
- PAHC $16.16
- 52 Week High
- PDM $11.12
- PAHC $31.80
- Technical
- Relative Strength Index (RSI)
- PDM 59.27
- PAHC 80.09
- Support Level
- PDM $7.33
- PAHC $24.59
- Resistance Level
- PDM $7.71
- PAHC $31.80
- Average True Range (ATR)
- PDM 0.22
- PAHC 0.96
- MACD
- PDM 0.01
- PAHC 0.52
- Stochastic Oscillator
- PDM 84.38
- PAHC 87.79
About PDM Piedmont Office Realty Trust Inc.
Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across major U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.